Olmetec, as an angiotensin II receptor antagonist, is mainly used for the treatment of hypertension. Its usage needs to be adjusted according to the individual situation of the patient, and special attention should be paid to liver and kidney function and pregnancy status when using it in special populations. The following is an explanation from three aspects: conventional usage, dosage adjustment, and medication for special populations. Please consult a doctor for specific details.
1. Conventional usage and dosage
(1) Initial dose: Adults typically start with a dose of 20mg once daily, which can achieve maximum blood pressure lowering effect within 2 weeks.
(2) Dosage adjustment: Depending on blood pressure control, it can be increased to 40mg/day, taken in single or divided doses, with a maximum dose not exceeding 40mg/day.
(3) Medication time: It is recommended to take it at the same time every day, both before and after meals, but the administration method should be consistent.
2. Dose adjustment for special populations
(1) Liver dysfunction
The initial dose for Child Pugh B patients is halved (10mg/day), while it is contraindicated for Child Pugh C patients.
(2) Renal insufficiency
When the creatinine clearance rate is less than 20mL/min, the initial dose is 10mg/day. Patients with end-stage renal disease need to closely monitor blood pressure and renal function.
(3) Elderly patients
Patients aged 65 and above do not require routine dose adjustments, but for frail elderly patients, it is recommended to gradually increase the dosage from 10mg/day.
3. Precautions for medication for special populations
(1) Pregnancy period: Use in the middle and late stages of pregnancy can cause fetal damage or even death. If pregnancy is detected, the medication should be stopped immediately.
(2) Breastfeeding period: Rat studies have shown that drugs are secreted into breast milk, but human data is insufficient. It is recommended to stop breastfeeding during the medication period.
(3) Children: The safety and efficacy of using it for patients under 18 years old have not been established and is not recommended.
(4) Dialysis patients: Hemodialysis cannot effectively remove drugs, medication should be administered after dialysis and blood pressure should be closely monitored.
Disclaimer:《Usage, Dosage, and Special Population Use of Olmetec in Japan》Edited and sorted by Seagull Pharmacy's editors. Please contact us in time if there is any infringement. In addition, the suggestions for drug usage, dosage and disease mentioned in the article are only for medical staff's reference, and can not be used as any basis for medication!
Full Name:Olmesartan Medoxomil、Olmetec®ODTablets、 奥美沙坦酯、傲坦、オルメテック
Reference Price:$325.00
Prescribing Information: 奥美沙坦酯由日本第一三共株式会社原研开发,是血管紧张素II受体拮抗剂(ARB)类药物中的重要成员。 一、药品名称 奥美沙坦酯(OlmesartanMedoxomil),商品名为“奥美泰克”(Olmetec)。 二、适应症 高血压症。 三、规格和性状 ...